Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Intuitive Machines (LUNR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Intuitive Machines — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.62 (market cap $31.07B), while Intuitive Machines trades at $10.84 (market cap $1.97B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 15.8× Intuitive Machines's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Intuitive Machines pays none. Which is the better fit depends on your goals.
| GEHC | LUNR | |
|---|---|---|
Market Cap | $31.07B | $1.97B |
Volume | 3,443,020 | 6,024,737 |
Sector | Health | Industrials |
52-Week High | $88.16 | $45.70 |
52-Week Low | $59.48 | $8.05 |
Enterprise Value | $39.53B | $2.04B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Intuitive Machines (LUNR) trades at $12.18, down 5.29% on the day, reflecting a bearish technical trend. The company is in a high-growth phase, with revenue projected to surge from $207 million in 2025 to $481 million in 2026, but it remains deeply unprofitable with a net loss margin of -27.1%. Recent news highlights its strategic position in lunar infrastructure and satellite manufacturing, supported by NASA contracts, though the stock faces pressure from broader sector weakness.
The investment case hinges on execution of its growth strategy amid significant cash burn. Analyst consensus is strongly bullish with an $31.33 price target, but high execution risk and persistent losses present a speculative opportunity. Key risks include dependence on government contracts and intense competition in the space sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Intuitive Machines
Intuitive Machines provides lunar access, data, and infrastructure services. Its capabilities include lunar landers, communications systems, and technologies designed to support missions to the Moon.
Read more on LUNR →
